"Drug Industry" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.
| Descriptor ID |
D004345
|
| MeSH Number(s) |
J01.576.655.750
|
| Concept/Terms |
Drug Industry- Drug Industry
- Industry, Pharmaceutic
- Industries, Pharmaceutic
- Pharmaceutic Industries
- Pharmaceutic Industry
- Industry, Drug
- Drug Industries
- Industries, Drug
- Industry, Pharmaceutical
- Industries, Pharmaceutical
- Pharmaceutical Industries
- Pharmaceutical Industry
|
Below are MeSH descriptors whose meaning is more general than "Drug Industry".
Below are MeSH descriptors whose meaning is more specific than "Drug Industry".
This graph shows the total number of publications written about "Drug Industry" by people in this website by year, and whether "Drug Industry" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 3 | 2 | 5 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 3 | 3 |
| 2010 | 2 | 1 | 3 |
| 2011 | 2 | 1 | 3 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 0 | 2 | 2 |
| 2019 | 2 | 0 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Industry" by people in Profiles.
-
Sridhar J. Current Digital Direct-to-Consumer Advertising-The Tip of the Iceberg. JAMA Ophthalmol. 2022 06 01; 140(6):642-643.
-
Watane A, Kalavar M, Reyes J, Yannuzzi NA, Sridhar J. The Effect of Market Competition on the Price of Topical Eye Drops. Semin Ophthalmol. 2022 Jan 02; 37(1):42-48.
-
Snyder CM, Hoyt K, Gouglas D, Johnston T, Robinson J. Designing Pull Funding For A COVID-19 Vaccine. Health Aff (Millwood). 2020 Sep; 39(9):1633-1642.
-
Wang JV, Chapman LW, Keller M, Zachary CB. Experiences of Dermatologic Surgeons With the Sunshine Act: A National Survey. Dermatol Surg. 2019 06; 45(6):864-867.
-
Niforatos JD, Pescatore RM. Financial relationships with industry among guideline authors for the management of acute ischemic stroke. Am J Emerg Med. 2019 05; 37(5):921-923.
-
Rup B, Pallardy M, Sikkema D, Albert T, Allez M, Broet P, Carini C, Creeke P, Davidson J, De Vries N, Finco D, Fogdell-Hahn A, Havrdova E, Hincelin-Mery A, C Holland M, H Jensen PE, Jury EC, Kirby H, Kramer D, Lacroix-Desmazes S, Legrand J, Maggi E, Maill?re B, Mariette X, Mauri C, Mikol V, Mulleman D, Oldenburg J, Paintaud G, R Pedersen C, Ruperto N, Seitz R, Spindeldreher S, Deisenhammer F. Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium. Clin Exp Immunol. 2015 Sep; 181(3):385-400.
-
Samuel AM, Webb ML, Lukasiewicz AM, Bohl DD, Basques BA, Russo GS, Rathi VK, Grauer JN. Orthopaedic Surgeons Receive the Most Industry Payments to Physicians but Large Disparities are Seen in Sunshine Act Data. Clin Orthop Relat Res. 2015 Oct; 473(10):3297-306.
-
McGregor AJ, Barr H, Greenberg MR, Safdar B, Wildgoose P, Wright DW, Hollander JE. Gender-specific Regulatory Challenges to Product Approval: a panel discussion. Acad Emerg Med. 2014 Dec; 21(12):1334-8.
-
Krane NA, Sataloff RT. Understanding the regulation of pharmaceutical drug promotion [Editorial]. Ear Nose Throat J. 2014 Dec; 93(12):486-8.
-
Skolnik N. Don't restrict funding from drug companies for doctors' education. BMJ. 2013 Nov 08; 347:f6452.